MAPT and Alzheimer disease: To account for potential differences in tau protein levels themselves or altered neuronal content of the samples, the fractions of P-S396 and P-T212 tau (canonical sites implicated in AD) were normalized to either total tau or the neuronal marker βIII-tubulin (TUBB3).